Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05041335 · ClinicalTrials.gov registry record · NA
Wet Heparinized Suction for Abdominal Cancer
A NA study, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- Not yet
- Registry status
- NA
- Development phase
- 42
- Enrollment target
NCT05041335 is a NA study that has not yet begun recruiting, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 42 participants.
The verdict
NCT05041335, a NA study, has not yet begun recruiting, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 42 participants
- Enrollment target
Study Summary
The purpose of this research is to compare the amount and quality of tissue obtained by EUS-FNB when the device is flushed with an anticoagulant or "blood thinner" vs. saline a salt water solution as well as the use of a microsieve in order for the doctor to look at the tissue to check the acceptability of the specimens before sending for analysis. You will be randomly assigned (like a flip of a coin) to have either the blood thinner or the salt water solution placed within the needle being used to sample your abdominal tumor and to have either a sieve used or not. You will be one of 42 participants enrolled in this data collection study which includes 1 sites in the United States.
Interventions
- OTHER wet heparinzed suction
- OTHER Microsieve
- OTHER No heparin flush
- OTHER No microsieve
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2026-03-15 |
| Est. Completion | 2027-01-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05041335
The ClinicalTrials.gov registry entry for NCT05041335 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is H. Lee Moffitt Cancer Center and Research Institute, which has 502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which wet heparinzed suction is the first listed.
NCT05041335 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05041335 about?
NCT05041335 is a clinical study titled "Wet Heparinized Suction for Abdominal Cancer". The purpose of this research is to compare the amount and quality of tissue obtained by EUS-FNB when the device is flushed with an anticoagulant or "blood thinner" vs. saline a salt water solution as well as the use of a microsieve in order for the doctor to look at the tissue to check the acceptabi...
What is the current status of trial NCT05041335?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 42 participants. The study started on 2026-03-15. Estimated completion is 2027-01-12.
What interventions are being tested in trial NCT05041335?
The interventions under investigation include: wet heparinzed suction (OTHER), Microsieve (OTHER), No heparin flush (OTHER), No microsieve (OTHER).
Who is sponsoring clinical trial NCT05041335?
This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.